|
|
|
|
|
非在研适应症- |
最高研发阶段批准上市 |
|
首次获批日期2015-05-27 |
靶点- |
作用机制- |
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期1994-02-17 |
Evaluate Efficacy and Safety of DKP21102_B Added on to DKP21102_A Compared With DKP21102_A in Mixed Dyslipidemia Patients
Phase 3 study to evaluate the efficacy and safety of DKP21102_B Added on to DKP21102_A Compared with DKP21102_A
100 项与 Dongkwang Pharm Co. Ltd. 相关的临床结果
0 项与 Dongkwang Pharm Co. Ltd. 相关的专利(医药)
100 项与 Dongkwang Pharm Co. Ltd. 相关的药物交易
100 项与 Dongkwang Pharm Co. Ltd. 相关的转化医学